Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - OPERATING INCOME
Operating Income KALV - KalVista Pharmaceuticals, Inc.
-140 M
LAST VALUE
-20.57%
2 YEAR CAGR
-36.33%
5 YEAR CAGR
-39.00%
10 YEAR CAGR